Advertisement

Eicosanoid Metabolism and Endothelial Cell Adhesion Molecule Expression: Effects on Platelet/Vessel Wall Interactions

  • Michael R. Buchanan
  • Maria C. Bertomeu
  • Stephanie J. Brister
  • Thomas A. Haas
Part of the Altschul Symposia Series book series (ALSS, volume 1)

Abstract

Platelet interactions with the blood vessel wall following injury influence both the acute thrombotic event (platelet/vessel wall adhesion) and the chronic pathogenesis of arteriosclerosis (chronic vessel wall thickening and occlusion). Platelets are thought not to interact with the healthy intact endothelium, but only to adhere to vessel wall components exposed following endothelial cell damage and vessel wall injury (1–3). When platelets adhere to the injured vessel wall, they release a number of constituents which facilitate further platelet activation (3), activation of the coagulation cascade (1), and/or are mitogenic, facilitating smooth muscle cell proliferation and hyperplasia (4). Endothelial cells also synthesize and release a number of constituents which counterbalance the platelet responses, thereby enhancing fibrinolysis, inhibiting coagulation and preventing platelet aggregation and adhesion (5–7). Recently, with the development of endothelial cell culture techniques and a number of molecular biologic tools, we have learned that platelets and other blood cells actively interact not only with the injured vessel wall, but also with the intact endothelium itself. In this chapter, we will focus on the latter interaction and specifically on endothelial cell fatty acid metabolism and its possible consequence on the reactivity of adhesion molecule receptors on the surface of the intact endothelium which in turn may influence platelet/vessel wall interactions.

Keywords

Linoleic Acid Arachidonic Acid Vessel Wall Tumor Cell Adhesion Lipoxygenase Pathway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ross R. Atherosclerosis: A problem of the biology of arterial wall cells and their interaction with blood components. Arteriosclerosis 1: 293–311, 1981.PubMedCrossRefGoogle Scholar
  2. 2.
    Ross R. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med. 314: 488–500, 1986.PubMedCrossRefGoogle Scholar
  3. 3.
    Packham, M.A. and Mustard, J.F. The role of platelets in the development and complications of atherosclerosis. Semin. Hematol. 23: 8–26, 1986.PubMedGoogle Scholar
  4. 4.
    Nilsson, J. Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis 62: 185–99, 1986.PubMedCrossRefGoogle Scholar
  5. 5.
    Buchanan, M.R. Mechanisms of pathogenesis of arterial thrombosis: potential sites of inhibition by therapeutic compounds. Semin. Thromb. Haemost. 14: 33–40, 1988.CrossRefGoogle Scholar
  6. 6.
    Collen, D. Potential approaches for therapeutic intervention of thrombosis by fibrinolytic agents. Semin. Thromb. Haemost. 14: 95–99, 1988.CrossRefGoogle Scholar
  7. 7.
    Turpie, A.G.G. Clinical studies: evidence for intervention with specific antiplatelet drugs in arterial thromboembolism. Semin. Thromb. Haemost. 14: 41–49, 1988.CrossRefGoogle Scholar
  8. 8.
    Rossi, V., Breviario, F., Ghezzi, P., Dejana, E. and Mantovani, A. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 229: 174–176, 1985.PubMedCrossRefGoogle Scholar
  9. 9.
    Buchanan, M.R., Haas, T.A., Lagarde, M. and Guichardant, M. 13-Hydroxy- octadecadienoic acid is the vessel wall chemorepellent factor, LOX. J. Biol. Chem. 260: 16056–16059, 1985.PubMedGoogle Scholar
  10. 10.
    Bastida, E., Almirall, L., Ordinas, A., Buchanan, M.R., Bertomeu, M.C. and Haas, T.A. Effects of antiplatelet drugs and cytokines on endothelial cell 13-HODE synthesis and tumor cell/endothelial cell adhesion. Thromb. Haemost. 62: 138, 1989.Google Scholar
  11. 11.
    Haas, T.A., Bertomeu, M.C., Bastida, E. and Buchanan, M.R. Cyclic AMP regulation of endothelial cell triglyceride turnover, 13-hydroxyoctadecadienoic acid (13-HODE) synthesis and endothelial cell thrombogenicity. Biochem. Biophvs. Acta. 1031: 174–178, 1990.CrossRefGoogle Scholar
  12. 12.
    Ingerman-Wolenski, C., Silver, M.I., Smith, J.B. and Macarack, E. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J. Clin. Invest. 67: 1291–1296, 1981.Google Scholar
  13. 13.
    Ali, A.E., Banet, J.C. and Eling, T.E. Prostaglandin and thromboxane production by fibroblasts and vascular endothelial cells. Prostaglandins 20: 667–668, 1988.Google Scholar
  14. 14.
    Moncada, S. and Vane, J.R. Arachidonic acid metabolites and the interaction between platelet and blood vessel wall. New Engl. J. Med. 300: 1142–1147, 1979.PubMedCrossRefGoogle Scholar
  15. 15.
    Gorman, R.R., Bunting, S. and Miller, D.V. Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 13: 377–388, 1977.PubMedCrossRefGoogle Scholar
  16. 16.
    Hajjar, D.P., Weksler, B.B., Falcone, D.J., Hefton, D.M., Tack-Goldman, K. and Minick, C.R. Prostacyclin modulates cholesteryl ester hydrolyte activity by its effects on cyclic adenosine monophosphate in rabbit aorta smooth muscle cells. J. Clin. Invest. 70: 479–488, 1982.PubMedCrossRefGoogle Scholar
  17. 17.
    Weiss, H.J. and Turitto, V.T. Prostacyclin (prostaglandin I2) inhibits platelet adhesion and thrombus formation in subendothelium. Blood 53: 200–244, 1979.Google Scholar
  18. 18.
    Greenwald, J.E., Bianchine, J.R. and Wong, L.K. The production of the arachidonate metabolite HETE in vascular tissue. Nature 281: 588–589, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    Hopkins, N.K., Oglesby, T.D., Bundy, G.L. and Gorman, R.R. Biosynthesis and metabolism of 13 hydroperoxy 5,8,11,15 eicosatetraenoic acid by human umbilical vein endothelial cells. J. Biol. Chem. 259: 14048–14058, 1984.PubMedGoogle Scholar
  20. 20.
    Kuhn, H., Ponicke, K., Hall, W., Weisner, R., Scheme, T. and Forster, W. Metabolism of (1-14C)-arachidonic acid by cultured calf aortic endothelial cells and evidence for the presence of lipoxygenase pathway. Prostaglandins Leukotrienes Med. 17: 291–303, 1988.CrossRefGoogle Scholar
  21. 21.
    Buchanan, M.R., Crozier, G. and Haas, T.A. Fatty acid metabolism and the vascular endothelial cell. New thoughts about old data. Haemost. 18: 360–375, 1988.Google Scholar
  22. 22.
    Denning, G.M., Figard, P.H., Kaduce, T.L. and Spector A. Role of triglycerides in endothelial cell arachidonic acid metabolism. J. Lipid. Res. 24: 993–1011, 1983.PubMedGoogle Scholar
  23. 23.
    Buchanan, M.R., Butt, R.W., Magas, Z., Van Ryn, J., Hirsh, J. and Nazir, D.J. Endothelial cells produce a lipoxygenase derived chemorepellent which influences platelet/endothelial cell interactions. Effect of aspirin and salicylate. Thromb. Haemost. 53: 306–311, 1985.PubMedGoogle Scholar
  24. 24.
    Weber, E., Haas, T.A., Hirsh, J. and Buchanan, M.R. Relationship between vessel wall 13-HODE production and subendothelial basement membrane thromboresistance: Influence of salicylate. Thromb. Haemost. 58: 316, 1987.Google Scholar
  25. 25.
    Kaduce, T.L., Figard, P.H., Laifur, R. and Spector, H.H. Formation of 9hydroxyoctadecadienoic from linoleic acid in endothelial cells. J. Biol. Chem. 264: 68236830, 1988.Google Scholar
  26. 26.
    Bertomeu, M.C., Crozier, G.L., Haas, T.A., Fleith, M. and Buchanan, M.R. Dietary fats, vessel wall 13-HODE synthesis and vessel wall thrombogenecity. Thromb. Haemost. 62: 24, 1989.Google Scholar
  27. 27.
    Brister, S.J., Bertomeu, M.C., Haas, T.A., Austin, J. and Buchanan, M.R. Coronary artery bypass grafts: Variations in vessel wall thrombogenecity with 13-HODE synthesis, patient age and vessel wall type. Adv. Prost. Leuk. Res. 20: 1990, in press.Google Scholar
  28. 28.
    Buchanan, M.R. and Bastida, E. Endothelium and underlying membrane reactivity with platelets, leukocytes and tumor cells: regulation by the lipoxygenase-derived fatty acid metabolites 13-HODE and HETEs. Med. Hynoth. 27: 317–325, 1988.CrossRefGoogle Scholar
  29. 29.
    Bastida, E., Bertomeu, M.C., Haas, T.A., Almirall, L., Lauri, D., Orr, F.W. and Buchanan, M.R. Regulation of tumor cell adhesion by intracellular 13-HODE:15-HETE ratio. J. Lipid. Med.: 1990, in press.Google Scholar
  30. 30.
    Van Ryn McKenna, J. and Buchanan, M.R. Relative effects of flurbiprofen on platelet I 2-hydroxyeicosatetraenoic acid and thromboxane A2 production: influence on collagen-induce platelet aggregation and adhesion. Prostaglandins Leuko. Essent. Fatty Acids 36: 171–174, 1989.CrossRefGoogle Scholar
  31. 31.
    Grossi, I.M., Fitzgerald, L.A., Umbarger, L.A., Nelson, K.K., Diglio, C.A., Taylor, J.D. and Koon, K.V. Bidirectional control of membrane expression and/or activation of the tumor cell IRGp IIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Res. 49: 1029–1037, 1989.PubMedGoogle Scholar
  32. 32.
    Bertomeu, M.C., Haas, T.A., Eltringham-Smith, L. and Buchanan, M.R. Relationship between endothelial cell vitronectin receptor expression and 13-HODE: Histoimmunofluorescent localization. Proc. VIth Intl. Sym. Vascular Wall Cells, Paris, August, 1990.Google Scholar
  33. 33.
    Singer, I.I., Scott, S. Kawka, W. and Dazizis. Adhesomes: specific granules containing receptors for laminin, C3bi/fibrinogen, fibronectin, and vitronectin in human polymorphonuclear leukocytes and monocytes. J. Cell. Biol. 109: 3169–3182, 1989.PubMedCrossRefGoogle Scholar
  34. 34.
    Conforti, G., Zanetti, I., Pasquali-Ronchetti, D., Qualino, Jr. P., Negroz, P. and Dejana, R. Modulation of vitronectin receptor binding by membrane lipid composition. J. Biol. Chem. 265: 4011–4019, 1990.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Michael R. Buchanan
    • 1
  • Maria C. Bertomeu
    • 1
  • Stephanie J. Brister
    • 1
  • Thomas A. Haas
    • 1
  1. 1.Departments of Pathology and SurgeryMcMaster UniversityHamiltonCanada

Personalised recommendations